Triomics is a healthcare IT startup that develops technology to assist cancer care providers with patient data management. The company utilizes a specialized family of oncology-focused language models known as OncoLLM™ to automate the review of patient charts. This technology is designed to reduce the administrative burden on medical staff and support strategic clinical priorities.
Triomics was founded by the Triomics Team. The organization is a launched startup currently based in San Francisco, California, and operates as a remote-friendly company.
OncoLLM™ is a proprietary family of large language models developed by Triomics specifically for the oncology field. These models are used to process and analyze patient records to accelerate clinical trial enrollment and power quality improvement projects. By focusing on oncology-specific data, the models provide more specialized insights than general-purpose AI tools.
Triomics helps accelerate clinical trial enrollment by automating the manual process of reviewing patient charts. Its OncoLLM™ technology can identify eligible candidates for trials more quickly and accurately than traditional manual methods. This allows cancer care providers to increase participation in clinical research with less manual effort.
Triomics is headquartered in San Francisco, CA. The company is currently in the launched stage and offers full-time opportunities with a remote-friendly work environment.
Triomics addresses the high burden of manual patient chart reviews in oncology departments. By utilizing specialized AI to automate these reviews, the platform helps healthcare providers manage data more efficiently, improve quality control, and focus on strategic healthcare priorities rather than administrative tasks.